174P Safety and efficacy of anlotinib plus docetaxel in advanced non-small cell lung cancer patients after failure of first-line chemotherapy: Recent results from the ongoing phase II study (ALTER-L024)

Details

Language :

English

ISSN :

15560864 and 15561380

Volume :

16

Issue :

4, Number 4 Supplement 1

Database :

Supplemental Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Periodical

Accession number :

ejs55652764

Full Text :

https://doi.org/10.1016/S1556-0864(21)02016-5